2024
Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options
Mestre-Bach G, Potenza M. Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options. CNS Drugs 2024, 38: 255-265. PMID: 38485889, DOI: 10.1007/s40263-024-01075-2.Peer-Reviewed Original ResearchConceptsCompulsive sexual behavior disorderSexual behavior disorderReuptake inhibitorsBehavioral disordersPornography usePharmacological treatmentCo-occurring disordersEmpirical supportSerotonin reuptake inhibitorsCo-occurring conditionsMood stabilizersPsychiatric disordersPsychological therapiesTricyclic antidepressantsGeneralizability of resultsOpioid antagonistSerotonin antagonistsDisordersSerotoninPharmacological optionsPharmacological approachesAntagonistPharmacological therapyNarrative reviewNefazodonePharmacological management of gambling disorder: an update of the literature
Mestre-Bach G, Potenza M. Pharmacological management of gambling disorder: an update of the literature. Expert Review Of Neurotherapeutics 2024, 24: 391-407. PMID: 38357896, DOI: 10.1080/14737175.2024.2316833.Peer-Reviewed Original ResearchGambling disorderCo-occurring disordersSerotonin reuptake inhibitorsPlacebo response ratesOpioid receptor antagonistMental health conditionsGlutamatergic agentsNeurobiological correlatesGambling subtypesMood stabilizersReuptake inhibitorsClasses of medicationsPharmacological treatmentBetting behaviorGamblingTreatment responsePharmacological interventionsDisordersPharmacological managementMedicationTreatment optionsNarrative reviewLongitudinal informationResponse rateNalmefene
2023
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna P, Farahdel E, Potenza M, Crowley M. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder. Expert Opinion On Pharmacotherapy 2023, 24: 835-847. PMID: 37074259, PMCID: PMC10197951, DOI: 10.1080/14656566.2023.2199921.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSelective serotonin reuptake inhibitorsSelective norepinephrine reuptake inhibitorGeneralized anxiety disorderAnxiety disordersReuptake inhibitorsPediatric generalized anxiety disorderBetter long-term outcomesSecond-line treatmentNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsFirst-line interventionLong-term outcomesCombination of psychotherapyPrevalent psychiatric disordersEvidence-based statePediatric anxiety disordersArt pharmacotherapyModerate effect sizeFunctional outcomeEarly recognitionMood disordersElevated riskPsychiatric disordersBetter outcomesElectronic databases
2008
The Treatment of Pathologic Gambling
Brewer J, Grant J, Potenza M. The Treatment of Pathologic Gambling. Addictive Disorders & Their Treatment 2008, 7: 1-13. DOI: 10.1097/adt.0b013e31803155c2.Peer-Reviewed Original ResearchPharmacologic therapyPathologic gamblingSelective serotonin reuptake inhibitorsPharmacologic treatment studiesSerotonin reuptake inhibitorsStandardized outcome measuresComparison of interventionsPreliminary positive resultsSelf-help programReuptake inhibitorsOpioid antagonistSpecific therapyOutcome measuresConsistent efficacyTreatment studiesBehavioral treatmentLarger studyTherapySpecific subpopulationsResults MultiplePharmacotherapyTreatmentPositive resultsAvailable literatureEfficacy